CHPT1 and metabolic dysfunction-associated steatotic liver disease: PPARγ and CHPT1: Du S et al. Integration of network pharmacology, lipidomics, and transcriptomics analysis to reveal the mechanisms underlying the amelioration of AKT-induced nonalcoholic fatty liver disease by total flavonoids in vine tea.